Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HORACE MANN EDUCATORS CORP /DE/ insiders sold a net $2.8M of stock across 110 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
44 earlier Form 4 trades (code P or S) here by this insider (44 sales), the last on Oct 15, 2026.
The trade is 1.6% of the 293,884 shares held after it.
No other insider sold within 30 days.
145 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO ZURAITIS MARITA sold about $220.4K of HMN under a 10b5-1 plan on Oct 16, 2026; 145 funds added in the latest 13F quarter.
43 earlier Form 4 trades (code P or S) here by this insider (43 sales), the last on Oct 8, 2026.
The trade is 0.7% of the 298,651 shares held after it.
No other insider sold within 30 days.
145 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO ZURAITIS MARITA sold about $96.4K of HMN under a 10b5-1 plan on Oct 15, 2026; 145 funds added in the latest 13F quarter.
42 earlier Form 4 trades (code P or S) here by this insider (42 sales), the last on Oct 6, 2026.
The trade is 0.2% of the 300,734 shares held after it.
No other insider sold within 30 days.
145 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO ZURAITIS MARITA sold about $25.3K of HMN under a 10b5-1 plan on Oct 8, 2026; 145 funds added in the latest 13F quarter.
41 earlier Form 4 trades (code P or S) here by this insider (41 sales), the last on Sep 1, 2026.
The trade is 0.0% of the 301,284 shares held after it.
No other insider sold within 30 days.
145 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO ZURAITIS MARITA sold about $4.6K of HMN under a 10b5-1 plan on Oct 6, 2026; 145 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 12.9% of the 25,117 shares held after it.
4 other insiders sold within 30 days.
145 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hines Perry G. sold about $169.0K of HMN on Sep 3, 2026; 4 other insiders sold within 30 days and 145 funds added in the latest 13F quarter.
110 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HMN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
ZURAITIS MARITA
Filed 2026-10-16
$220.4K
ZURAITIS MARITA
Filed 2026-10-15
$96.4K
ZURAITIS MARITA
Filed 2026-10-08
$25.3K
ZURAITIS MARITA
Filed 2026-10-06
$4.6K
Carley Donald M
Filed 2026-09-03
$107.4K
HMN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON EQUITY INCOME FUND
$2.2M position · as of 2026-06-30
4.9%
ICON EQUITY FUND
$2.2M position · as of 2026-06-30
3.7%
ETC 6 Meridian Small Cap Equity ETF
$3.0M position · as of 2026-05-31
2.4%
Wasatch Small Cap Value Fund
$29.1M position · as of 2026-06-30
2.1%
SA Franklin Small Company Value Portfolio
$6.1M position · as of 2026-07-31
2.0%
Franklin Small Cap Value VIP Fund
$26.4M position · as of 2026-06-30
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Ms. Zuraitis
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.5M
$12.3M
$1.4M
+31%
+110%
2024
$8.2M
$9.9M
$1.4M
+8%
+102%
2023
$6.1M
$4.2M
$1.3M
-13%
+59%
2022
$5.1M
$5.1M
$1.1M
-5%
+46%
2021
$6.1M
$5.6M
$1.3M
-5%
+32%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.8M sold by insiders over 180 days, 145 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $1.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.7B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HMN
FY Dec 2025
$1.7B
FY Dec 2024
$1.6B
FY Dec 2023
$1.5B
FY Dec 2022
$1.4B
FY Dec 2021
$1.3B
Jun 2026
$443.5M
Mar 2026
$429.3M
Dec 2025
$434.8M
Sep 2025
$438.5M
Jun 2025
$411.7M
Mar 2025
$416.4M
Dec 2024
$409.0M
Sep 2024
$412.1M
At each fiscal year end
Single quarter
Net margin, TTM
+10.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM HMN
FY Dec 2025
+9.5%
FY Dec 2024
+6.4%
FY Dec 2023
+3.0%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+9.4%
Mar 2026
+9.6%
Dec 2025
+8.3%
Sep 2025
+13.3%
Jun 2025
+7.1%
Mar 2025
+9.2%
Dec 2024
+9.3%
Sep 2024
+8.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM HMN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.40x
long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity HMN
FY Dec 2025
0.40x
FY Dec 2024
0.42x
FY Dec 2023
0.46x
FY Dec 2022
0.45x
FY Dec 2021
0.34x
Jun 2026
0.40x
Mar 2026
0.40x
Dec 2025
0.40x
Sep 2025
0.58x
Jun 2025
0.40x
Mar 2025
0.41x
Dec 2024
0.42x
Sep 2024
0.42x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.95x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end)
Cash flow to debt HMN
FY Dec 2025
0.93x
FY Dec 2024
0.83x
FY Dec 2023
0.55x
FY Dec 2022
0.34x
FY Dec 2021
0.41x
Jun 2026
0.95x
Mar 2026
0.80x
Dec 2025
0.93x
Sep 2025
0.73x
Jun 2025
1.11x
Mar 2025
0.95x
Dec 2024
0.83x
Sep 2024
0.66x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity HMN
FY Dec 2025
+11.7%
FY Dec 2024
+8.3%
FY Dec 2023
+4.0%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+12.4%
Mar 2026
+11.7%
Dec 2025
+11.7%
Sep 2025
+12.0%
Jun 2025
+10.9%
Mar 2025
+9.0%
Dec 2024
+8.3%
Sep 2024
+8.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HMN
FY Dec 2025
+1.1%
FY Dec 2024
+0.7%
FY Dec 2023
+0.3%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+1.2%
Mar 2026
+1.1%
Dec 2025
+1.1%
Sep 2025
+1.1%
Jun 2025
+1.0%
Mar 2025
+0.8%
Dec 2024
+0.7%
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HMN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HMN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.86x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HMN
FY Dec 2025
11.84x
FY Dec 2024
15.82x
FY Dec 2023
30.00x
FY Dec 2022
79.51x
FY Dec 2021
9.58x
Jun 2026
12.07x
Mar 2026
10.72x
Dec 2025
11.84x
Sep 2025
11.44x
Jun 2025
12.71x
Mar 2025
15.48x
Dec 2024
15.82x
Sep 2024
13.87x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.4B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end), minus cash 2026-06-30
Enterprise value HMN
FY Dec 2025
$2.4B
FY Dec 2024
$2.1B
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$2.6B
Mar 2026
$2.3B
Dec 2025
$2.4B
Sep 2025
$2.6B
Jun 2025
$2.3B
Mar 2025
$2.3B
Dec 2024
$2.1B
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield HMN
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.41x
P/E over trailing EPS growth of 27%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing HMN
FY Dec 2025
0.21x
FY Dec 2024
0.12x
FY Dec 2023
0.23x
FY Dec 2022
n/a
FY Dec 2021
0.35x
Jun 2026
0.45x
Mar 2026
0.24x
Dec 2025
0.21x
Sep 2025
0.20x
Jun 2025
0.18x
Mar 2025
0.20x
Dec 2024
0.12x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HMN ranks highest on risk and compliance (69th percentile) and financial health (50th), and lowest on insider conviction (25th), among Insurance peers.
Profitability
38
Inputs
Return on equity+12.4% · 43 pct, sector of 116
Return on assets+1.2% · 34 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
50
Inputs
Debt to equity0.40x · 37 pct, sector of 104
Cash flow to debt0.95x · 64 pct, sector of 97
Growth
42
Inputs
Revenue growth, YoY+6.7% · 42 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
25
Inputs
Net Form 4 buying (codes P and S), 180d-$2.1M · 51 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
44
Inputs
Funds adding, latest quarter145 · 48 pct, sector of 108
Congress net buyers, 365d0 · 40 pct, universe of 718
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
Short interest, % of float+2.6% · 69 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HMN filings, in plain words
Are Horace Mann Educators insiders buying or selling HMN?
In the 180 days to 2026-10-28, Horace Mann Educators insiders were net sellers, a net $2.8M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded HMN?
Yes. In the year to 2026-10-28, 1 House member disclosed buying HMN and 1 House member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-20.
Are there planned insider sales of HMN?
Yes. 9 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.5M of stock; the latest, by ZURAITIS MARITA, was filed 2026-10-16.
Read the full summary
In the 180 days to 2026-10-28, Horace Mann Educators insiders were net sellers of HMN, a net $2.8M across purchases and sales reported on Form 4 by 5 sellers. 29% of the 17 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying HMN and 1 member disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-08-20. Insiders filed 9 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.